TY - JOUR
T1 - Research priorities for cancers of the oesophagus and stomach
T2 - recommendations from a UK and Ireland patient and healthcare professional partnership exercise
AU - Jones, Christopher M.
AU - Ng, Wee Han
AU - Tincknell, Laura
AU - Mcclurg, Dylan P.
AU - Adam, Emily
AU - Bhandari, Pradeep
AU - Campbell, Karen
AU - Chambers, Pinkie
AU - Ciccarelli, Francesca
AU - Coleman, Helen G.
AU - Crosby, Tom
AU - Doyle, Carmel
AU - Dunn, Jason M.
AU - Elliott, Jessie
AU - Fitzgerald, Rebecca C.
AU - Foley, Kieran G.
AU - Goh, Vicky
AU - Grabsch, Heike
AU - Graham, Trevor A.
AU - Grocott, Mike
AU - Gwynne, Sarah
AU - Harvey, Jo
AU - Jansen, Marnix
AU - Lagergren, Pernilla
AU - Lamb, Claire
AU - Leigh-Doyle, Lauren
AU - Malik, Farida
AU - Mayland, Catriona
AU - Mccord, Mimi
AU - Moss, Alan
AU - Mukherjee, Somnath
AU - Petty, Russell
AU - Rananaware, Siddharth
AU - Reid, Joanne
AU - Rubin, Gregory
AU - Smyth, Elizabeth
AU - Trudgill, Nigel J.
AU - Turkington, Richard C.
AU - Underwood, Timothy J.
AU - Walter, Fiona M.
AU - Williams, Jessica
AU - Peters, Christopher J.
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Background Cancers of the oesophagus and stomach are a major cause of morbidity and mortality. Research is crucial to improving outcomes. However, to maximise value and impact, areas of focus should be prioritised in partnership with patients. Objective We undertook a comprehensive analysis of UK and Ireland patient and healthcare professional (HCP) priorities for research into oesophagogastric cancers across the domains of prevention, diagnosis and staging, treatment, palliative care and survivorship. Design A scoping exercise sourced research questions from patients and HCPs. These were consolidated and then confirmed by systematic review to represent a true research uncertainty. Research questions were scored on potential impact by an interdisciplinary group of HCPs and prioritised using a weighting derived from a patient survey. Results There were 835 (395 HCP, 440 patient) respondents to the scoping (n=455) and prioritisation (n=380) surveys. Across these, 4295 suggested research uncertainties were consolidated to 92 uncertainties that were prioritised. HCP respondents represented 25 professional groups from community and hospital settings. Patient weighting changed 22.2-46.3% of priority rankings established by HCPs. All domains were represented by the 20 highest priority questions, 5 of which focused on personalising and optimally combining treatment modalities. Two other key themes related to optimising nutrition and improving quality of life during and after treatment, including in patients not cured of their cancer. Conclusion This work highlights the impact of patient input on HCP-ranked research priorities and provides a robust list of priorities to guide funders, policymakers and researchers to support and undertake impactful research.
AB - Background Cancers of the oesophagus and stomach are a major cause of morbidity and mortality. Research is crucial to improving outcomes. However, to maximise value and impact, areas of focus should be prioritised in partnership with patients. Objective We undertook a comprehensive analysis of UK and Ireland patient and healthcare professional (HCP) priorities for research into oesophagogastric cancers across the domains of prevention, diagnosis and staging, treatment, palliative care and survivorship. Design A scoping exercise sourced research questions from patients and HCPs. These were consolidated and then confirmed by systematic review to represent a true research uncertainty. Research questions were scored on potential impact by an interdisciplinary group of HCPs and prioritised using a weighting derived from a patient survey. Results There were 835 (395 HCP, 440 patient) respondents to the scoping (n=455) and prioritisation (n=380) surveys. Across these, 4295 suggested research uncertainties were consolidated to 92 uncertainties that were prioritised. HCP respondents represented 25 professional groups from community and hospital settings. Patient weighting changed 22.2-46.3% of priority rankings established by HCPs. All domains were represented by the 20 highest priority questions, 5 of which focused on personalising and optimally combining treatment modalities. Two other key themes related to optimising nutrition and improving quality of life during and after treatment, including in patients not cured of their cancer. Conclusion This work highlights the impact of patient input on HCP-ranked research priorities and provides a robust list of priorities to guide funders, policymakers and researchers to support and undertake impactful research.
KW - GASTRIC CANCER
KW - OESOPHAGEAL CANCER
KW - BARRETT'S OESOPHAGUS
KW - SQUAMOUS-CELL CARCINOMA
KW - PERIOPERATIVE CHEMOTHERAPY
KW - GASTRIC-CANCER
KW - ADENOCARCINOMA
KW - PROJECTIONS
KW - LANDSCAPE
U2 - 10.1136/gutjnl-2025-336421
DO - 10.1136/gutjnl-2025-336421
M3 - Article
SN - 0017-5749
VL - 74
SP - 1949
EP - 1961
JO - Gut
JF - Gut
IS - 12
ER -